Previous findings suggest that mTORC1 plays a role in podocyte dysfunction and DKD, and we found that mTORC1 elevation in Tsc1-deleted macrophages significantly upregulated CFB expression, suggesting that mTORC1 may stimulate complement alternative pathway activation to promote podocyte injury and DKD. The gene discussed is CFB; the disease is diabetic kidney disease.